Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer

NCT00030641 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: oblimersen sodium
DRUG: docetaxel

Sponsor

Genta Incorporated

Collaborators

[object Object]